Sulfasalazine Tablet, Delayed Release
Product Images NDC 11534-201

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sulfasalazine (NDC 11534-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sunrise Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

This is a description of Sulfasalazine Delayed-Release Tablets, USP, with each tablet containing 500 mg of sulfasalazine. It is a prescription-only medication provided in a bulk container of 100 tablets. The dosage and usage instructions are mentioned on the accompanying prescribing information. The tablets are not meant for household use and should be stored in a well-closed container at a temperature of 25°C (77°F) with excursions allowed between 15-30°C (59-86°F). This medication is manufactured for Sunrise Pharmaceutical, Inc. located in Rahway, NJ 07065. The revision date provided is 06/2023.*

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

This is a description of Sulfasalazine Delayed-Release Tablets, USP, each containing 500 mg of sulfasalazine. The container includes 300 tablets and is intended for bulk use only, not for household use. The recommended storage is at 25°C (77°F) with excursions between 15-30°C (59-86°F). Detailed dosage and usage instructions are provided separately. The tablets were manufactured by Sunrise Pharmaceutical, Inc. in Rahway, NJ 07065.*

FDA Label Image

Chemical Structure (Sulfasalazine 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.